These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 567712)

  • 21. Asymmetric septal hypertrophy in autopsies in men.
    Robinson JJ
    Arch Pathol Lab Med; 1976 Mar; 100(3):121-2. PubMed ID: 130093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Relation of electrocardiographic features and distribution of hypertrophy in hypertrophic non-obstructive cardiomyopathy during childhood].
    Kamiya Y; Oonaka M; Itoi T; Hamaoka K; Onouchi Z
    J Cardiol; 1994; 24(2):91-106. PubMed ID: 8164151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcoronary ablation of septal hypertrophy (Tash).
    Sathyamurthy I
    Indian Heart J; 2006; 58(4):371-4. PubMed ID: 19039161
    [No Abstract]   [Full Text] [Related]  

  • 24. [Pathophysiology of asymmetric septal hypertrophy with special reference to the response to isoproterenol administration].
    Iida K; Sugishita Y; Matsuda M; Yamaguchi T; Ajisaka R; Matsumoto R; Fujita T; Ito I
    J Cardiogr; 1984 Jun; 14(1):85-93. PubMed ID: 6240510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of dobutamine stress on basal septal tissue dynamics in hypertensive patients with basal septal hypertrophy.
    Yalçin F; Yigit F; Erol T; Baltali M; Korkmaz ME; Müderrisoglu H
    J Hum Hypertens; 2006 Aug; 20(8):628-30. PubMed ID: 16761028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypertrophic cardiomyopathy.
    Sasson Z; Rakowski H; Wigle ED
    Cardiol Clin; 1988 May; 6(2):233-88. PubMed ID: 3066484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tetralogy of Fallot, hypertrophic cardiomyopathy, and Down's syndrome: a rare and challenging combination.
    Wheeler YY; Russo P; Carter GA; Lababidi Z; Luger AM; Tobias JD
    Pediatr Dev Pathol; 2006; 9(4):307-11. PubMed ID: 16944989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electrophysiological characteristics of septal hypertrophy in patients with hypertrophic obstructive cardiomyopathy and moderate to severe symptoms.
    Schumacher B; Gietzen FH; Neuser H; Schümmelfeder J; Schneider M; Kerber S; Schimpf R; Wolpert C; Borggrefe M
    Circulation; 2005 Oct; 112(14):2096-101. PubMed ID: 16186424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specificity of light and electron microscopic features of hypertrophic obstructive and nonobstructive cardiomyopathy. Qualitative, quantitative and etiologic aspects.
    Ferrans VJ; Rodríguez ER
    Eur Heart J; 1983 Nov; 4 Suppl F():9-22. PubMed ID: 6686548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Asymmetric septal hypertrophy in childhood. Unreliability of histologic criteria for differentiation of obstructive and nonobstructive forms.
    Edwards WD; Zakheim R; Mattioli L
    Hum Pathol; 1977 May; 8(3):277-84. PubMed ID: 140144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraventricular muscle band mimicking asymmetric ventricular septal hypertrophy and hypertrophic cardiomyopathy.
    Maron BJ; Klues HG; McIntosh C
    Am J Cardiol; 1992 Jul; 70(1):130-1. PubMed ID: 1615861
    [No Abstract]   [Full Text] [Related]  

  • 32. Asymmetric septal hypertrophy (ASH): the unifying link in the IHSS disease spectrum. Observations regarding its pathogenesis, pathophysiology, and course.
    Henry WL; Clark CE; Epstein SE
    Circulation; 1973 Apr; 47(4):827-32. PubMed ID: 4266759
    [No Abstract]   [Full Text] [Related]  

  • 33. [Detection of regional hypertrophy in hypertrophic cardiomyopathy with ECG triggered nuclear magnetic resonance tomography--comparison with hypertensive patients and persons with healthy hearts].
    Schneider R; Köhler D; Berghöfer G; Paeprer H; Felix R; Thormann I; Schörner W; Schmutzler H
    Z Kardiol; 1985 Mar; 74(3):144-51. PubMed ID: 3158127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delayed hyper-enhancement of myocardium in hypertrophic cardiomyopathy with asymmetrical septal hypertrophy: comparison with global and regional cardiac MR imaging appearances.
    Amano Y; Takayama M; Takahama K; Kumazaki T
    J Magn Reson Imaging; 2004 Oct; 20(4):595-600. PubMed ID: 15390225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of hypereosinophilic syndrome with asymmetric septal hypertrophy.
    Nunoda S; Genda A
    Heart Vessels; 1991; 6(2):116-20. PubMed ID: 2071548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isometric cardiac contraction. a possible cause of the disorganized myocardial pattern of idiopathic hypertrophic subaortic stenosis.
    Bulkley BH; Weisfeldt ML; Hutchins GM
    N Engl J Med; 1977 Jan; 296(3):135-9. PubMed ID: 556638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Noninvasive and invasive study procedures in hypertrophic cardiomyopathy].
    Sheikhzadeh A; Stierle U; Diederich KW
    Herz; 1985 Apr; 10(2):59-71. PubMed ID: 4039292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinico-pathomorphologic evaluation of changes of the interventricular heart septum in hypertrophic cardiomyopathy].
    Rozenberg VD
    Kardiologiia; 1990 Feb; 30(2):66-9. PubMed ID: 2348623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in distribution of myocardial abnormalities in patients with obstructive and nonobstructive asymmetric septal hypertrophy (ASH). Light and electron microscopic findings.
    Maron BJ; Ferrans VJ; Henry WL; Clark CE; Redwood DR; Roberts WC; Morrow AG; Epstein SE
    Circulation; 1974 Sep; 50(3):436-46. PubMed ID: 4278057
    [No Abstract]   [Full Text] [Related]  

  • 40. Number and size of myocytes, amount of interstitial space and extent of disarray of the hearts in patients with systemic hypertension and asymmetric septal hypertrophy.
    Fujiwara H; Fujiwara T; Hamashima Y; Kawai C
    Jpn Circ J; 1985 Apr; 49(4):406-14. PubMed ID: 4040182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.